Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus

Journal of Neurochemistry

Volumn 87, Issue 1, 2003, Pages 195-204

  Chacón, Marcelo A ^a   Reyes, Ariel E ^a,b   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DIEGO PORTALES   (Chile)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Intrahippocampal injection; Neurotoxicity; Spatial memory; Water maze

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID; AMYLOID BETA PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR DISORDER; CELL LOSS; CELL STRUCTURE; CHICKEN; COGNITIVE DEFECT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; HYPERTROPHY; IMMUNOREACTIVITY; IN VIVO STUDY; MAZE TEST; NERVE CELL; NEUROBLASTOMA CELL; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARAMETER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RETINA; SCORING SYSTEM; SPATIAL MEMORY; SWIMMING; TIME;

ACETYLCHOLINESTERASE; ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; CATTLE; DRUG ADMINISTRATION ROUTES; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; MALE; MAZE LEARNING; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

ANIMALIA; GALLUS GALLUS; HIPPOCAMPUS HIPPOCAMPUS; MAMMALIA;

EID: 0141642240     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01985.x     Document Type: Article

References (68)

1. Alvarez A., Opazo C., Alarcón R., Garrido J. and Inestrosa N. C. (1997) Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils. J. Mol. Biol. 272, 348-361.
2. Alvarez A., Alarcón R., Opazo C. et al. (1998) Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18, 3213-3223.
3. Arendt T., Bruckner M. K., Lange M. and Bigl V. (1992) Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - a study of molecular forms. Neurochem. Int. 21, 381-396.
4. Atack J. R., Perry E. K., Bonham J. R., Perry R. H., Tomlinson B. E., Blessed G. and Fairbaim A. (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type: selective loss of the intermediate (I OS) form. Neurosci. Lett. 40, 199-204.
5. Baxter M. G., Bucci D. J., Gorman L. K., Wiley R. G. and Gallagher M. (1995) Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. Behav. Neurosci. 109, 714-722.
6. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M. and Soreq H. (1995) Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 9, 1063-1071.
7. Beeri R., Le Novere N., Mervis R., Huberman T., Grauer E., Changeux J. P. and Soreq H. (1997) Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69, 2441-2451.
8. Bigbee J. W., Sharma K. V., Chan E. L. and Bogler O. (2000) Evidence for the direct role of acetylcholinesterase in neurite outgrowth in primary dorsal root ganglion neurons. Brain Res. 861, 354-362.
9. Bronfman F. C., Moechars D. and Van Leuven F. (2000) Acetylcholinesterase-positive fiber deaffearentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice. Neurobiol. Dis. 2000 7, 152-168.
10. Calderón F. H., von Benhardi R., De Ferrari G., Luza S., Aldunate R. and Inestrosa N. C. (1998) Toxic effect of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol. Psych. 3, 247-255.
11. Cohen O., Erb C., Ginzberg D., Pollak Y., Seidman S., Shoham S., Yirmiya R. and Soreq H. (2002) Neuronal overexpression of 'readthrough' acetylcholinesterase is associated with antisense-suppressible behavioral impairments. Mol. Psych. 7, 874-885.
12. Cotê S. L., Ribeiro-Da-Silva A. and Cuello A. C. (1993) Current protocols for light microscopy immunocytochemistry, In Immunohistochemistry II (Cuello A. C., ed). pp. 147-168. Wiley, Chichester.
13. Cummings B. J., Su J. H. and Cotman C. W. (1993) Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Exp. Neurol. 124, 315-325.
14. Davies P. and Maloney A. J. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2, 1403.
15. Day T. and Greenfield S. A. (2002) A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurones in vitro: molecular mechanisms. Neuroscience 111, 649-656.
16. De Ferrari G. V., Canales M. A., Shin I., Weiner L. M., Silman I. and Inestrosa N. C. (2001) A structural motif of acetylcholinesterase that promotes amyloid β-peptide fibril formation. Biochemistry 40, 10 447-10 457.
17. DeKosky S. T. and Scheff S. W. (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27, 457-464.
18. Dubois B., Mayo W., Agid Y., Le Moal M. and Simon H. (1985) Profound disturbances of spontaneous and learned behaviors following lesions of the nucleus basalis magnocellularis in the rat. Brain Res. 338, 249-258.
19. Duffy P. E., Rapport E. M. and Graf L. (1990) Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 30, 778-782.
20. Ellman G. L., Courtney K. D., Andress V. and Featherstone R. M. (1961) A new rapid colorimetic determination of acetylcholinesterase activity. Biochem. Pharmacol. 1, 88-95.
21. Erb C., Troost J., Kopf S., Schmitt U., Loffelholz K., Soreq H. and Klein J. (2001) Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. 77, 638-646.
22. Fishman E. B., Siek G. C., MacCallum R. D., Bird E. D., Volicer L. and Marquis J. K. (1986) Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann. Neurol. 19, 246-252.
23. Flicker C., Dean R. L., Watkins D. L., Fisher S. K. and Bartus R. T. (1983) Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol. Biochem. Behav. 18, 973-981.
24. Fodero L. R., Sáez-Valero J., McLean C. A., Martins R. N., Beyreuther K., Masters C. L., Robertson T. A. and Small D. H. (2002) Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J. Neurochem. 81, 441-448.
25. Geula C. and Mesulam M. (1989) Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res. 498, 185-189.
26. Geula C. and Mesulam M. (1994) Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease, in Alzheimer Disease (Terry R. D., Katzman R. and Bick K. L., eds), pp. 263-269. Raven Press, New York.
27. Gómez-Ramos P., Mufson E. J. and Morán M. A. (1992) Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil and senile plaques in aged and Alzheimer's brain. Brain. Res. 569, 229-237.
28. Greenfield S. (1996) Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28, 485-490.
29. Greenfield S. and Vaux D. J. (2002) Parkinson's disease, Alzheimer's disease and motor neurone disease: identifying a common mechanism. Neuroscience 113, 485-492.
30. Hagan J. J., Jansen J. H. and Broekkamp C. L. (1987) Blockade of spatial leaming by the MI muscarinic antagonist pirenzepine. Psychopharmacology (Berl.) 93, 470-476.
31. Holmes C., Jones S. A., Budd T. C. and Greenfield S. A. (1997) Noncholinergic, trophic action of recombinant acetylcholinesterase on mid-brain dopaminergic neurons. J. Neurosci. Res. 49, 207-218.
32. Hyman B. T., Van Hoesen G. W., Damasio A. R. and Barnes C. L. (1984) Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 225, 1168-1170.
33. Inestrosa N. C. and Perelman A. (1989) Distribution and anchoring of the molecular forms of acetylcholinesterase. Trends Pharmacol. Sci. 10, 325-329.
34. Inestrosa N. C. and Reyes A. E. (1998) Acetylcholinesterase induces amyloid formation and increases neurotoxicity of Alzheimer's fibrils. Neurobiol. Aging 19, S44 (Abst.).
35. Inestrosa N. C., Roberts W. L., Marshall T. D. and Rosenberry T. L. (1987) Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterases in other tissues. J. Biol. Chem. 262, 4441-4444.
36. Inestrosa N. C., Alvarez A., Pérez C., Moreno R., Vicente M., Linker C., Casanueva O. I., Soto C. and Garrido J. (1996) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme. Neuron 16, 881-891.
37. Kalaria R. N., Kroon S. N., Grahovac I. and Perry G. (1992) Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease. Neuroscience 51, 177-184.
38. Kasa P., Rakonczay Z. and Gulya K. (1997) The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52, 511-535.
39. Kato S., Kimura Y., Misaki N., Nakahiro M. and Yoshida H. (1989) Blockade of ACh receptors by PrBCM causes deficits in shuttle avoidance performance. Pharmacol. Biochem. Behav. 33, 895-898.
40. Kaufer D., Friedman A., Seidman S. and Soreq H. (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393, 373-377.
41. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
42. Levin E. D., Castonguay M. and Ellison G. D. (1987) Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav. Neural. Biol. 48, 206-212.
43. Mandel R. J., Gage F. H. and Thal L. J. (1989) Spatial learning in rats: correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage. Exp. Neurol. 104, 208-217.
44. Miyamoto M., Kato J., Narumi S. and Nagaoka A. (1987) Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats. Brain Res. 419, 19-31.
45. Morán M. A., Mufson M. and Gómez-Ramos P. (1993) Colocalization of cholinesterases with β-amyloid protein in aged and Alzheimer's brain. Acta Neuropathol. 85, 362-369.
46. Morris R. G. M. (1984) Developments of a water maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11, 47-60.
47. Morris R. G. M. (1995) Spatial learning with a minislab in the dorsal hippocampus. Proc. Natl Acad. Sci. USA 92, 9697-9701.
48. Muñoz F. J. and Inestrosa N. C. (1999) Neurotoxicity of acetylcholinesterase-amyloid β-peptide aggregates is dependent on the type of Aβ-peptide and the AChE concentration present in the complexes. FEBS Lett. 450, 205-209.
49. Muñoz F. J., Aldunate R. and Inestrosa N. C. (1999) Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase. NeuroReport 10, 3621-3625.
50. Muñoz F. J., Opazo C., Gil-Gómez G., Tapia G., Fernández V., Valverde M. A. and Inestrosa N. C. (2002) Vitamin E but not 17β-Estradiol protects against vascular toxicity induced by β-amyloid wild-type and the Dutch amyloid variant. J. Neurosci. 22, 3081-3089.
51. Ohno M., Yamamoto T. and Watanabe S. (1994) Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats. Brain Res. 650, 260-266.
52. Olton D. S. (1979) Mazes, maps and memory. Am. Psychol. 34, 583-596.
53. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, London.
54. Pike C. J., Cummings B. J. and Cotman C. W. (1995) Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp. Neurol. 132, 172-179.
55. Rees T., Hammond O., Soreq H., Younkin S. and Brimijoin S. (2003) Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol. Aging 24, 777-787.
56. Reyes A. E. (2000) Characterization of New Animal Models for the Study of Alzheimer's Disease. PhD Thesis Dissertation, Faculty of Biological Sciences, Pontifical Catholic University of Chile, Santiago, Chile.
57. Selkoe D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 8, 741-766.
58. Sharma K. V., Koenigsberger C., Brimijoin S. and Bigbee J. W. (2001) Direct evidence for an adhesive function in the noncholinergic role of acetylcholinesterase in neurite outgrowth. J. Neurosci. Res. 63, 165-175.
59. Shen Z. X. (1994) Acetylcholinesterase provides deeper insights into Alzheimer's disease. Med. Hypoth. 43, 21-30.
60. Small D. H., Michaelson S. and Sbema G. (1996) Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28, 453-483.
61. Smith A. D. and Cuello A. C. (1984) Alzheimer's disease and acetylcholinesterase-containing neurons. Lancet 1, 513.
62. Squire L. R. (1993) The hippocampus and spatial memory. Trends Neurosci. 16, 56-57.
63. Sternfeld M., Ming G., Somg H., Sela K., Timberg R., Poo M. and Soreq H. (1998) Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J. Neurosci. 18, 1240-1249.
64. Sternfeld M., Shoham S., Klein O., Flores-Flores C., Evron T., Idelson G. H., Kitsberg D., Patrick J. W. and Soreq H. (2000) Excess 'readthrough' acetylcholinesterase attenuates but the 'synaptic' variant intensifies neurodeterioration correlates. Proc. Natl Acad. Sci. USA 97, 8647-8652.
65. Struble R. G., Cork L. C., Whitehouse P. J. and Price D. L. (1982) Cholinergic innervation in neuritic plaques. Science 216, 413-415.
66. Stürchler-Pierrat C., Abramowski D., Duke M. et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer's disease-like pathology. Proc. Natl Acad. Sci. USA 94, 13 287-13 292.
67. Talesa V. N. (2001) Acetylcholinesterase in Alzheimer's disease. Mech. Ageing Dev. 122, 1961-1969.
68. Younkin S. G., Goodridge B., Katz J., Lockett G., Nafziger D., Usiak M. F. and Younkin L. H. (1986) Molecular forms of acetylcholinesterase in Alzheimer's disease. Fed. Proc. 45, 2982-2988.